Interventional Ultrasound Application for Urology
Early management of disease leads to better patient care and reduces socio-economic impacts. This is why Esaote has been investing in preventive healthcare for many years, aiming to deliver precise and reliable diagnosis to meet any clinical need and approach.
Interventional settings require dedicated features and solutions that allow the accurate treatment of any type of patient. Esaote is committed to providing the shortest and most effective path to patient care from diagnosis, advanced biopsy guidance and follow-up.
Fast, safe, and efficacious Solutions in Urology
Esaote offers Innovative Clinical Solutions from Prevention to Therapy, increasing Productivity Efficiency and Value. For all solutions, which cover the major focus areas, patient care and user experience are key factors.
Prevention & Diagnosis
Early management of disease leads to better patient care and reduces socio-economic impacts. This is why Esaote has been investing in preventive healthcare for many years, aiming to deliver precise and reliable diagnosis to meet any clinical need. Integrated solutions for data and image management ensure safe and streamlined workflow.
- Maximum B-Mode contrast resolution
- Blood flow sensitivity (HD CFM, XFlow, microV)
- Contrast Media examination (CnTI)
- Elastosonography (ElaXto)
CnTI™ (Contrast Tuned Imaging) is Esaote’s advanced technology for Contrast Enhanced Ultrasound (CEUS) Imaging. Based on low mechanical index and real-time scanning, CnTI™ is an ideal way to use second generation contrast media. CnTI™ Data can be fused with MRI, CT, PET, 3D Ultrasound and/or 3D CEUS volumes.
Real-time B-Mode scanning fusion with CnTI™ Volume enables constant CEUS anatomical references during interventional procedures.
Elastosonography technology allows the user to perform an elastosonographic analysis of the tissue, providing information about the tissue’s elasticity by associating different chromatic patterns to the different tissue elasticity responses. ElaXto in urology applications is available with endocavity and bi-plane transducers for prostate and a wide range of linear transducers for testes.
elaXto increases clinical information using in Urology for monitoring, biopsy guidance, characterization and follow up.
Therapy & Follow-up
Interventional settings require dedicated features and solutions that allow the accurate treatment of any type of patient. Esaote is committed to providing the shortest and most effective path to patient care.
- Dedicated biopsy guidance (also with Virtual Biopsy) and percutaneous ablation kits
- Fusion Imaging (Virtual Navigator) with dedicated U.I. for Urology
- Customized protocols for Biopsy, Criotherapy and Ablation Procedures
- Biopsy Stepper (compatible with Fusion Imaging)
Biopsy/Ablation kits and Virtual Biopsy
Esaote offers a wide range of dedicated transducers and kits: clinical examinations and biopsy operations can be comfortably performed with the right tool and without any waste of time.
For each probe, dedicated biopsy and ablation kits are available, with the possibility of tracking the biopsy needle in the 3D space or any other external device.
Virtual Biopsy combined with Intelligent Positioning increases confidence during ultrasound real-time biopsy procedures, thanks to virtual tracking of the needle – helping users to reach the target quickly, precisely and safely. The physical needle is highlighted by a virtual needle on the real-time ultrasound image with complete 3D representation of the probe, scanning plane and pathway to the target.
Colored targets can be visualized and the needle will become a gunshot viewfinder.
Fusion Imaging in Urology
In the field of minimally invasive techniques, the need for technological improvements has been increasing dramatically in past few years.
One of the most interesting and promising techniques is the TRUS-MRI navigation system for prostate biopsy thanks to the fact that different imaging modalities could be fused with intrinsic, real-time modalities, such as U.S., to enhance localization capabilities.
Virtual Navigator is Esaote’s revolutionary technology for fusion Imaging that allows CT, MR and PET side by side with real-time ultrasound. Virtual Navigator takes all the advantages of different modalities and provides a real-time, low-cost and radiation-free solution that aims to guide operators in diagnosis, everyday clinical practice, interventional procedures, research and teaching. Virtual Navigator increases your diagnostic confidence.
A dedicated environment has been developed to assist users during cryotherapy, radiofrequency, microwaves and laser ablations offering manual delineation of lesion margins and computed calculation of lesion volume, definition of expected necrotic ellipse and needle tracking capability for several brands of needles.
Stepper grid for prostate procedures: planning and guiding
Esaote offers the possibility of performing advanced procedures such as brachytherapy and thermal ablation with a trans-perineal approach, making use of the biplane probe TRT33 and Classic Stepper by CIVCO. A biopsy grid visualization will guide the operator to ensure accurate positioning for prostate cancer detection, targeting, and treatment. In combination with real-time Esaote Fusion Imaging, a dedicated environment has been developed to assist users during cryotherapy, radiofrequency, microwave, and laser ablations.
Grid layout with real-time ultrasound
Grid for prostate procedures on Virtual Navigator
In addition to the real-time visualization of the matrix grid in combination with Classic Stepper, Virtual Navigator enables:
- Delineation of lesion margins and computed calculation of lesion volume,
- Definition of expected necrotic ellipse,
- Needle tracking capability for several brands of needles,
- Sample detection and 3D tracking,
- Targeted biopsy and ablation procedures with multiple kits available
- Possibility of tracking the biopsy needle in 3D or with any other external device.
ClassicStepper™ is a trademark of CIVCO Medical Solutions. Product images are for illustrative purposes only.
CnTI™: The use of Contrast Agents in the USA is limited by FDA to the left ventricle opacification and to characterization of focal liver lesions.
Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. Product images are for illustrative purposes only. For further details, please contact your Esaote sales representative.